Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation by cross-linked truncated and chimeric full-length beta-amyloid

D H Cribbs1, P Velazquez, B Soreghan

  • 1Institute for Brain Aging and Dementia, Department of Neurology, University of California Irvine, 92697-4540, USA.

Neuroreport
|January 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Links between international market trends, agricultural intensification and extreme sedimentation rates in a transboundary South American coastal lagoon.

The Science of the total environment·2025
Same author

Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology.

Neurobiology of disease·2019
Same author

CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films.

Journal of materials chemistry. B·2017
Same author

Synthesis and release of sucrose by the aleurone layer of barley: Regulation by gibberellic acid.

Planta·2014
Same author

Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model.

Molecular psychiatry·2012
Same author

Transgenic mice as a model of pre-clinical Alzheimer's disease.

Current Alzheimer research·2010
Same journal

Electroacupuncture alleviates neuroinflammation and promotes recovery of neurological functions after intracerebral hemorrhage by modulating α7nAChR/JAK2/STAT3 signaling pathway.

Neuroreport·2026
Same journal

Non-cell-autonomous regulation of Bhlhb5 expression in cortical projection neurons by GABAergic interneuron development and position.

Neuroreport·2026
Same journal

C-C motif chemokine ligand 3 mediates inflammatory response via NLRP3 inflammasome and neuron damage after traumatic brain injury.

Neuroreport·2026
Same journal

Methyltransferase-like 14 alleviates neuronal ferroptosis in Alzheimer's disease by regulating the peroxiredoxin 6/apoptosis signal-regulating kinase 1 signaling pathway.

Neuroreport·2026
Same journal

Hand mental rotation reaction time reflects motor imagery strategy and predicts changes in finger dexterity after motor imagery.

Neuroreport·2026
Same journal

Functional exploration of metabotropic glycine receptors in cultured rat hippocampal slices.

Neuroreport·2026
See all related articles

Beta-amyloid (A beta) fibrils activate the complement system, a key part of inflammation in Alzheimer's disease. Specific structural features, not C-terminal residues, are crucial for this complement activation.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Beta-amyloid (A beta) aggregation and complement activation are implicated in Alzheimer's disease pathogenesis.
  • Understanding the structural requirements for A beta-mediated complement activation is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the structural parameters of beta-amyloid fibrils necessary for complement system activation.
  • To determine the role of A beta C-terminal residues in fibril formation and complement activation.

Main Methods:

  • Induction of beta-sheet-rich A beta1-28 fibrils using low pH.
  • Chemical cross-linking of A beta fibrils to stabilize beta-sheet conformation.
  • Assessment of chimeric A beta peptides with modified C-terminal sequences for fibril formation and complement activation.

Related Experiment Videos

Main Results:

  • Both chemically cross-linked A beta1-28 and chimeric A beta peptides formed beta-sheet-rich fibrils.
  • These modified A beta fibrils demonstrated strong activation of the classical complement pathway.
  • Results indicate C-terminal residues facilitate fibril assembly but are not direct interaction sites for complement activation.

Conclusions:

  • A fibrillar, beta-sheet-rich conformation of A beta is essential for effective complement activation.
  • The N-terminal hydrophilic domain of A beta likely serves as the binding site for C1q.
  • These findings refine the understanding of A beta's role in Alzheimer's-related neuroinflammation.